Saturday 17 October 2026
Export CGNX’s income statement to Excel — free account
Cognex Corporation
CGNX Technology Scientific & Technical Instruments
Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024. In the quarter to June 2026, revenue grew 16.9%, EPS grew 79.2% and free cash flow grew 67.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
54.11
1.56
−2.80%
Follow CGNX
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 14.01 | 31.18 | 34.88 | 35.60 | 35.20 | 72.85 | 40.21 | 34.28 | 34.79 | 22.67 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 32.98 | 72.99 | 70.00 | 57.31 | 83.10 | 101.82 | 80.30 | 59.51 | 53.13 | 49.76 | |||||
| People | |||||||||||||||
| People | Employees | 1,421 | 1,771 | 2,124 | 2,267 | 2,055 | 2,257 | 2,441 | 2,992 | 2,914 | 2,745 | ||||
| Revenue/emp, $m | 0.37 | 0.43 | 0.38 | 0.32 | 0.39 | 0.46 | 0.41 | 0.28 | 0.31 | 0.36 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 530 | 766 | 806 | 726 | 811 | 1,037 | 1,006 | 838 | 915 | 994 | ||||
| Gross margin, % | 75.25 | 75.55 | 74.45 | 73.85 | 74.55 | 73.26 | 71.75 | 71.79 | 68.43 | 66.92 | |||||
| EBT | 162 | 266 | 235 | 163 | 187 | 319 | 251 | 135 | 131 | 183 | |||||
| EBT margin, % | 30.61 | 34.78 | 29.09 | 22.46 | 23.05 | 30.75 | 24.92 | 16.16 | 14.38 | 18.38 | |||||
| Net income | 144 | 177 | 219 | 204 | 176 | 280 | 216 | 113 | 106 | 114 | |||||
| Depreciation | 15 | 17 | 22 | 24 | 28 | 25 | 25 | 24 | 33 | 30 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 3.10 | 4.42 | 4.68 | 4.24 | 4.67 | 5.88 | 5.80 | 4.86 | 5.33 | 5.92 | ||||
| Earnings | 0.88 | 1.02 | 1.27 | 1.19 | 1.02 | 1.59 | 1.24 | 0.66 | 0.62 | 0.68 | |||||
| Cash flow | 1.07 | 1.29 | 1.30 | 1.48 | 1.40 | 1.78 | 1.40 | 0.66 | 0.87 | 1.46 | |||||
| Capex | (0.08) | (0.17) | (0.22) | (0.13) | (0.08) | (0.09) | (0.11) | (0.13) | (0.09) | (0.01) | |||||
| Free cash flow | 0.99 | 1.13 | 1.08 | 1.35 | 1.32 | 1.69 | 1.29 | 0.52 | 0.78 | 1.45 | |||||
| Book value | 5.64 | 6.32 | 6.59 | 7.92 | 7.28 | 8.10 | 8.29 | 8.74 | 8.85 | 8.88 | |||||
| Shares, m | 171 | 173 | 172 | 171 | 173 | 176 | 173 | 172 | 171 | 168 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 35.95 | 60.18 | 30.45 | 47.49 | 79.23 | 48.91 | 38.34 | 61.12 | 57.84 | 52.14 | ||||
| P/S | 10.20 | 13.88 | 8.26 | 13.22 | 17.18 | 13.23 | 8.26 | 8.30 | 6.72 | 6.08 | |||||
| P/B | 5.61 | 9.71 | 5.87 | 7.08 | 11.04 | 9.60 | 5.78 | 4.62 | 4.05 | 4.05 | |||||
| EV/Sales | 9.40 | 13.36 | 7.60 | 12.65 | 16.72 | 12.92 | 7.86 | 7.90 | 6.45 | 5.74 | |||||
| EV/FCF | 31.36 | 55.28 | 34.84 | 41.53 | 62.01 | 46.50 | 37.09 | 83.37 | 47.76 | 24.50 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 182 | 224 | 223 | 253 | 242 | 314 | 243 | 113 | 149 | 246 | ||||
| Capex | (13) | (29) | (37) | (22) | (13) | (15) | (20) | (23) | (15) | (2) | |||||
| Free cash flow | 169 | 196 | 186 | 232 | 229 | 299 | 224 | 90 | 134 | 243 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 461 | 517 | 689 | 487 | 469 | 451 | 530 | 527 | 444 | 514 | ||||
| Total debt | — | — | — | 18 | 26 | 26 | 39 | — | — | — | |||||
| Net debt | (421) | (405) | (536) | (412) | (372) | (324) | (400) | (332) | (246) | (337) | |||||
| Shareholders’ equity | 963 | 1,096 | 1,135 | 1,356 | 1,262 | 1,430 | 1,438 | 1,505 | 1,518 | 1,492 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 14.92 | 15.19 | 17.01 | 12.84 | 9.56 | 14.71 | 10.88 | 5.70 | 5.29 | 5.71 | ||||
| ROIC | 17.77 | 23.41 | 23.05 | 9.44 | 11.98 | 17.80 | 14.82 | 6.97 | 5.66 | 8.80 | |||||
| ROE | 16.07 | 17.17 | 19.66 | 16.37 | 13.46 | 20.79 | 15.03 | 7.69 | 7.03 | 7.61 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Cognex Corporation vs peers in Scientific & Technical Instruments (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| FTV Fortive Corporation | $17.5B | 33.6× | 30.8× | +7.91% (above 0%: growing) | +6.12% (above 0%: growing) | −9.82% (below 0%: shrinking) | 63.39% | 19.14% | Compare |
| MKSI MKS Inc. | $15.5B | 32.9× | 37.4× | +28.26% (above 0%: growing) | +181.52% (above 0%: growing) | +38.97% (above 0%: growing) | 47.68% | 20.11% | Compare |
| TRMB Trimble Inc. | $14.2B | — (loss-making) | 24.1× | +11.00% (above 0%: growing) | n/m | +492.59% (above 0%: growing) | 69.43% | 13.58% | Compare |
| CGNX Cognex Corporation | $9.4B | 51.5× | 42.7× | +16.93% (above 0%: growing) | +79.17% (above 0%: growing) | +67.25% (above 0%: growing) | 70.65% | 29.36% | |
| ESE ESCO Technologies Inc. | $7.8B | 20.5× | 46.9× | +14.40% (above 0%: growing) | +24.75% (above 0%: growing) | −22.12% (below 0%: shrinking) | 41.74% | 14.80% | Compare |
| ST Sensata Technologies Holding N.V. | $6.0B | 66.5× | 16.9× | +5.00% (above 0%: growing) | +70.73% (above 0%: growing) | +61.39% (above 0%: growing) | 30.47% | 16.70% | Compare |
| NOVT Novanta Inc. | $5.1B | 81.0× | 62.9× | +10.27% (above 0%: growing) | +158.33% (above 0%: growing) | +391.84% (above 0%: growing) | 45.49% | 6.79% | Compare |
| VNT Vontier Corporation | $4.5B | 13.7× | 8.6× | −2.17% (below 0%: shrinking) | −67.74% (below 0%: shrinking) | +13.79% (above 0%: growing) | 48.24% | 19.39% | Compare |
| ITRI Itron, Inc. | $3.7B | 13.6× | 15.4× | −7.23% (below 0%: shrinking) | −19.33% (below 0%: shrinking) | −10.13% (below 0%: shrinking) | 40.97% | 13.51% | Compare |
| Median of peers | $6.9B | 32.9× | 27.5× | +9.09% | +24.75% | +26.38% | 46.59% | 15.75% |
Cognex Corporation (CGNX) key facts
- Strength: Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
- Cognex Corporation (CGNX) is a Scientific & Technical Instruments company in the Technology sector, listed on Nasdaq.
- As of October 16, 2026, CGNX traded at $54.11, a market capitalization of $9.4 billion.
- Cognex Corporation pays an annual dividend of $0.34 per share, a yield of 0.63%, with a payout ratio of 33.0%.
- Return on equity was 7.61% and debt-to-equity 0.00.
- Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 8.26 (safe zone) for fiscal 2025.